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Abstract
Background: Cushing’s disease is very rare in the paediatric population. Although uncommon, corticotroph hyperplasia
causing Cushing’s syndrome has been described in the adult population, but appears to be extremely rare in children.
Likewise, cyclical cortisol hypersecretion, while accounting for 15 % of adult cases of Cushing’s disease, has only rarely
been described in the paediatric population. Here, we describe a very rare case of a 13-year old boy with cyclical cortisol
hypersecretion secondary to corticotroph cell hyperplasia.
Case presentation: The case is that of a 13-year old boy, presenting with a long history of symptoms and signs suggestive
of hypercortisolism, who was found to have cyclical ACTH-dependent hypercortisolism following dynamic pituitary testing
and serial late-night salivary cortisol measurements. The patient underwent endoscopic transsphenoidal resection of
the pituitary. Early surgical remission was confirmed by undetectable post-operative morning plasma cortisol levels.
Histology and immunocytochemistry of the resected pituitary tissue showed extensive corticotroph cell hyperplasia.
Conclusion: This report describes a rare case of cyclical Cushing’s disease secondary to corticotroph hyperplasia in a
paediatric patient. This highlights the challenging and varied nature of Cushing’s disease and its diagnosis, and the
need to keep a differential diagnosis in mind during the diagnostic process.
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Background
Cushing’s disease is rare in the paediatric population, and is
invariably due to a corticotroph adenoma, usually a micro-
adenoma [1]. Corticotroph hyperplasia as a cause of
Cushing’s syndrome, although uncommon, has been
described in the adult population. However, this appears
to be extremely rare in children. Also, cyclical cortisol
hypersecretion, while accounting for 15 % of adult cases of
Cushing’s disease [2], has very rarely been described in the
paediatric population [3]. Here we describe the case of a
13-year old boy with cyclical cortisol hypersecretion
secondary to corticotroph cell hyperplasia, and review
the relevant literature with regard to paediatric Cushing’s
disease.
Case presentation
A 13 year-old boy was referred to the endocrine service
for evaluation. Our patient and his family described a
history of early adrenarche aged 5, and, beginning at age
9, the gradual onset of marked weight gain and develop-
ment of a rounded, plethoric facies. In retrospect,
proximal muscle weakness was also felt to have begun at
this time. He presented to his primary care practitioner
at the age of 12, and was referred on to a paediatric
endocrinology tertiary referral centre for further
assessment.
At initial assessment, weight was 95.9 kg (above the
99.6th centile) with a height of 147 cm (between 10- 25th
centile). He had markedly Cushingoid facies, an inter-
scapular fat pad, and increased abdominal girth with
striae, with objective evidence of proximal myopathy
(Fig. 1). Blood pressure was normal.
A 1 mg overnight dexamethasone suppression re-
vealed a post-suppression cortisol value of 258 nmol/L
(normal <50 nmol/l). Twenty-four hour urinary free
cortisol was markedly elevated at 987 nmol/24 h (reference
range 0–83 nmol/24 h). Given the characteristic clinical
picture, and 2 positive screening tests, a diagnosis of
Cushing’s syndrome was made. His ACTH level was not
suppressed, consistent with ACTH-dependent Cushing’s
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syndrome. A peripheral human corticotropin-releasing
hormone (CRH) test showed a greater than 50 % rise in
ACTH after 15 min, (60.1 pg/ml at 0 mins rising to
104 pg/ml at 15 mins), along with an almost 50 % rise in
cortisol (756 to 1126 nmol/L). This is highly characteristic
of pituitary dependent Cushing’s syndrome (Cushing’s
disease) [4]. A contrast-enhanced dynamic pituitary MRI
scan was performed, and interpreted by a specialist pituit-
ary neuroradiologist. This revealed a radiologically normal
pituitary gland.
On questioning, the patient reported fluctuations in
his symptoms with some days feeling more symptomatic
than others. To assess for the possibility of cyclical over-
secretion of ACTH/cortisol, we performed serial salivary
cortisol measurement, which has been shown to have
similar sensitivity to urine sampling for the detection of
cyclical hypercortisolism [5] (the patient was not taking
any medication that could interfere with the result). This
showed several peaks and two normal value troughs
(Fig 2), consistent with cyclical Cushing’s disease.
To confirm the diagnosis of pituitary dependant
Cushing’s syndrome, inferior petrosal sinus sampling
(IPSS) was performed under general anaesthesia with
samples obtained at baseline, and then at different time
points following CRH administration. Unfortunately, the
first test showed no central to peripheral gradient as it was
done on a day when the disease was not active. A repeat
IPSS was subsequently performed on a morning when the
disease was active - an early morning cortisol on the
morning of the procedure was 845 nmol/l, confirming
hypercortisolaemia. This second IPSS showed a marked
central to peripheral gradient (Left petrosal ACTH con-
centration at 0 mins > 2100 pg/ml, left peripheral ACTH
concentration 167 pg/ml at 0 mins). A marked left to right
gradient was also evident (Results summarised in Table 1).
This confirmed that the patient had Cushing’s disease.
The patient underwent endoscopic transsphenoidal
exploration of the pituitary by our dedicated pituitary
surgeon. This revealed abnormal soft tissue in the midline
and to the left of the pituitary fossa, all of which was
macroscopically removed at surgery. Aside from transient
diabetes insipidus, our patient’s post-operative course was
unremarkable. Several serial morning (8 am) serum cortisol
levels were all less than 28 nmol/l confirming early remis-
sion (defined as post-operative cortisol values < 50 nmol/L).
The patient was discharged on hydrocortisone 10 mgs
twice daily.
Histology and immunostaining
The excised surgical specimen consisted of adenohypoph-
ysis characterised by an admixture of cells arranged into
nests (Fig 3). Cells with eosinophilic cytoplasm and clear
cytoplasm, together with occasional cells having basophilic
cytoplasm were all present. Immunocytochemistry dem-
onstrated immunoreactivity for TSH, FSH, LH, and pro-
lactin. Additionally there was extensive widespread ACTH
Fig 1 Pictures taken the week prior to surgery, demonstrating increased abdominal circumference, striae, and Cushingoid facies
Fig 2 Late-night salivary cortisol over 10 consecutive days in a boy
with suspected Cushing’s disease. Dashed line represents upper limit
of normal for salivary cortisol (2.5 nmol/L)
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expression throughout all of the resected material.
There was no evidence of isolated focal ACTH immu-
nostaining in the resected pituitary tissue. ACTH im-
munostaining would have been markedly suppressed in
the non-adenomatous gland in the presence of an
ACTH-secreting pituitary adenoma if such an adenoma
was present in the gland, but not in the laboratory spe-
cimen (a phenomenon which is recognised in some
cases following successful neurosurgery for Cushing’s
disease). Also, reticulin staining demonstrated a normal
pericellular reticulin pattern, as opposed to the pattern
of reticulin disruption that would be expected if an
adenoma were present [6]. Therefore, this extensive
ACTH expression in the resected adenohypophysis tissue
reflected diffuse corticotroph cell hyperplasia.
Clinical course
Six weeks post-operatively, the patient underwent a gluca-
gon stimulation test, which showed severe growth hormone
deficiency and persistent severe hypocortisolaemia. The pa-
tient was started on recombinant human growth hormone
(GH) therapy. He later developed post-GH secondary
hypothyroidism and was treated with L-thyroxine. One year
later, he remained hypocortisolaemic, and reported excel-
lent progress. His weight has declined from a peak of 97 to
63 kg and his height has increased from 147 to 152 cm. His
Cushingoid features have also markedly improved.
Conclusion
Pituitary dependent Cushing’s syndrome is rare in the
paediatric population and is invariably due to cortico-
troph adenomas (1). In the adult population, multifocal
corticotroph hyperplasia has been shown to precede ad-
enoma development [7], and even to co-exist with aden-
omas [8–10]. However, several paediatric series have
been reported – the largest by far a 28-year prospective
study in the National Institutes of Health, describing 200
children [11], none of whom demonstrated evidence of
corticotroph hyperplasia as the aetiology of their Cushing’s
disease. The other large case series are all considerably
smaller by comparison, for example; a 15-year retrospect-
ive study from the Mayo Clinic reporting only 22 patients
[12], 33 cases described in the southern United States [13],
and 25 cases described in Britain [14]. However, none of
the paediatric patients in these case series demonstrated
corticotroph hyperplasia as the aetiology of their Cushing’s
disease. However, corticotroph hyperplasia as a cause of
Cushing’s disease in a paediatric patient was reported in a
single case from Finland [15]. Surprisingly, and in sharp
contrast with the American and British series, 3 of 15
patients in a Brazilian case series [16] were reported as
having increased numbers of ACTH staining cells with no
evidence of an adenoma but no detailed histology was
presented (10).
While the absence of an adenoma from the surgical
specimen following successful transsphenoidal surgery
for Cushing’s disease is sometimes seen [11], in this
case, the normal adenohypophysis should show marked
suppression of ACTH immunostaining due to negative
feedback from the long standing hypercortisolaemia
[17]. In our case, however, the resected adenohypophysis
showed markedly widespread ACTH immunopositivity
consistent with hyperplasia. In adults, corticotroph hyper-
plasia can very rarely be secondary to ectopic corticotropin-
releasing hormone secretion [18]. In our case, however,
the fact that the hyperplasia was focal, and that the pa-
tient went into remission following only partial resec-
tion of the pituitary makes secondary corticotroph
hyperplasia very unlikely; ongoing close observation is,
however, necessary.
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Although cyclical hypercortisolism can be demon-
strated in approximately 15 % of adult patients with
Cushing’s disease, and perhaps up to 40 % of adults with
Cushing’s syndrome [2, 19–21], it is much rarer in chil-
dren, Only 2 cases were observed in a large case series
of 59 paediatric patients with Cushing’s syndrome [22],
and only one case in a large series that included 17
paediatric patients [2]. There are only ten reports of cyclical
cortisol hypersecretion in the paediatric population in the
literature [3]. These are predominantly due to nodular
adrenocortical disease [22–24], although pituitary adenoma
[19], ectopic corticotropin secretion [22], and unknown
aetiology [25] have all been described. This therefore repre-
sents a very rare case of cyclical Cushing’s disease due to
corticotroph hyperplasia in a paediatric patient. The
demonstration of several late night salivary cortisol
peaks and two normal troughs makes this a robust diag-
nosis of cyclicity.
Cushing’s disease is associated with a high rate of
relapse, particularly in children [12], but early surgical re-
mission rates following transsphenoidal surgery are com-
parable to those in the adult population [26]. The finding
of severe postoperative hypocortisolism in the post-
operative period indicates a good longer-term prognosis
[11] (positive predictive value of 96 % for long-term remis-
sion in a paediatric population if postoperative morning
cortisol < 28 nmol/L in one series). However, due to the
cyclical nature of the original disease, close long-term
follow-up, with repeated biochemical testing as well as
clinical evaluation, will be essential for our patient. Most
recently, the desmopressin test has been proposed as a
useful predictor of recurrence of disease, either alone, or
in combination with the dexamethasone test [27]. It is
not, however, a well-established follow-up test for Cushing’s
disease in the paediatric population, and we therefore do
not have data on this.
This case illustrates the capricious nature of Cushing’s
disease and demonstrates the necessity of both keeping
a differential diagnosis in mind, and the utility of using
different methods of assessing cortisol secretion in this
diagnostically challenging condition.
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Fig 3 Resected adenohypophysis. Cells with eosinophilic cytoplasm and clear cytoplasm with occasional cells having basophilic cytoplasm are
seen on the left. The specimen on the right shows extensive ACTH staining without evidence of focal suppression
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